Sign in
Taking peopleNo phase

Comparing two iron medicines for children with iron deficiency anemia

Compares iron polymaltose complex with ferrous sulfate in young children with iron deficiency anemia.

Key facts

Who runs it
Arooj Khan
Where
Pakistan1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients
Status
Recruiting
People taking part
198 people, planned
Started
10 Jan 2024
Planned end
10 Jan 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Ferrous sulfate
  • Iron Polymaltose Complex
Record updated
19 December 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for young children with iron deficiency anemia, a low blood count caused by too little iron. It compares two iron medicines taken by mouth.

Age
6 Months to 5 Years
Sex
All
Disease stage
Iron deficiency anemia
Earlier treatment
Children who had a blood transfusion in the previous 4 weeks cannot join.

Main reasons for not taking part

  • Congenital aplastic anemia or thalassemia, both inherited blood disorders
  • Blood transfusion in the previous 4 weeks
  • Malabsorption syndrome, where the gut does not take up food well, or diarrheal illness
  • Bleeding in the gut, such as bloody vomit, black stools or bloody stools

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Patients having iron deficiency anemia

Who cannot take part

  • Patients who were transfused in previous 4 weeks (will be determined on history)
  • Children having mal-absorption syndrome and diarrheal illnesses. (will be determined on history and medical record)
  • Gastrointestinal bleeding suggested by history of hematemesis (bloody vomit), melena (black colored stools) or bloody stools
  • Patients diagnosed as congenital aplastic anemia or thalassemia (Determined from medical record)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to compare the efficacy of two iron preparation for the management of children presented with iron deficiency anemia. Ferrous sulphate and lron polymaltose (ferric form) are most commonly used preparations. Both drugs are easily available in market and are often recommended by pediatriclans. The efficacy, bioavail.tbilily, side effects and cost of these preparations vary. This study is designed to find out a drug with better efficacy that can be used for treatment of iron deficiency anemia in local population.

The 2 groups in the trial

  • Group A (Ferrous sulphate)Existing treatment, for comparison

    Group A will be given Ferrous sulphate in a dose of 6mg/kg/day of elemental iron once daily for 8 weeks orally in syrup form.

    Treatment: Ferrous sulfate

  • Group B (Iron Polymaltose complex)Existing treatment, for comparison

    Group B will be given Iron Polymaltose complex in a dose of 6mg/kg/day of elemental iron once daily orally for 8 weeks.

    Treatment: Iron Polymaltose Complex

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients With Iron Deficiency Anemia
Plain-language title
Comparing two iron medicines for children with iron deficiency anemiaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
19 December 2024